Immunic, Inc.
3 private offerings reported to the SEC on Form D since 2016, $340.0M sold in all. Biotech, United States.
- Form D offerings: 3
- Reported sold: $340.0M
- Newest: Mar 4, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Mar 4, 2026 | $200.0M | $200.0M | Immunic, Inc.Biotech · United States | Not amended | 0001193805-26-000217 |
| Jan 19, 2024 | $80.0M | $240.0M | Immunic, Inc.Biotech · United States | Not amended | 0001193805-24-000065 |
| Oct 18, 2022 | $60.0M | $60.0M | Immunic, Inc.Biotech · NY | Not amended | 0001193805-22-001424 |
SEC Profile
From the company's EDGAR record- Ticker
- IMUX
- Business address
- NEW YORK, United States
- Incorporated in
- DE
- SEC industry
- Pharmaceutical Preparations
- Former names
- Vital Therapies Inc
- All SEC filings
- CIK 1280776 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR